← Back to headlines
Immunic Secures $400M Financing for Phase 3 MS Data Readout
Immunic has secured $400 million in financing, setting the stage for the readout of its phase 3 multiple sclerosis (MS) data.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism
8h ago
Analysts Assess NVIDIA's Valuation and Volatility Risks Following Weekly Stock Decline
10h ago
Richtech Robotics Announces Stock Repurchase Program, Shares Rise
11h ago
Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale
12h ago